Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Nirsevimab beschermt tegen ondersteluchtweginfectie door RS-virus
okt 2021 | Virale infecties